The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 72 (4) , 746-760
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 86 references indexed in Scilit:
- Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cellsNature Biotechnology, 2012
- Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B CellsCell Metabolism, 2012
- A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma PatientsCancer Research, 2010
- Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysisNature Biotechnology, 2010
- Elimination of the CDP-ethanolamine Pathway Disrupts Hepatic Lipid HomeostasisJournal of Biological Chemistry, 2009
- Differential 12C-/13C-Isotope Dansylation Labeling and Fast Liquid Chromatography/Mass Spectrometry for Absolute and Relative Quantification of the MetabolomeAnalytical Chemistry, 2009
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell FeaturesGastroenterology, 2009
- Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growthMolecular Cancer Therapeutics, 2008
- Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesisProceedings of the National Academy of Sciences, 2007
- Developmental and Metabolic Effects of Disruption of the Mouse CTP:Phosphoethanolamine Cytidylyltransferase Gene (Pcyt2)Molecular and Cellular Biology, 2007